期刊文献+

前列腺电切术后膀胱过度活动症的药物疗效观察 被引量:7

下载PDF
导出
摘要 目的 探讨前列腺电切术后膀胱过度活动症应用托特罗定药物治疗的疗效观察。方法共入组病例64例。其中对照组为回顾性研究病例32例,术后给予应用硬膜外镇痛泵治疗。试验组32例,术后给予酒石酸托特罗定口服,2 mg,2次/d。观察疗效。结果对照组有效率87.5%,治愈率81.25%,复发率15.625%;试验组有效率93.75%,治愈率90.625%,无复发病例。结论酒石酸托特罗定治疗前列腺电切术后膀胱过度活动症疗效确切,方法简单,易于推广。
作者 彭昊
出处 《中国实用医药》 2011年第1期69-70,共2页 China Practical Medicine
  • 相关文献

参考文献3

  • 1张时纯 刘健湘.不稳定膀胱[J].中华泌尿外科杂志,1988,9(3):142-142.
  • 2孙元星,杨阔,胡生银,赵恒.自控硬膜外镇痛防治前列腺切除术后膀胱痉挛性疼痛的疗效观察[J].中国疼痛医学杂志,2005,11(4):251-251. 被引量:8
  • 3Malone-. Lee, Shaffu B, Anand C, et al. Tolterodine : superior tolerability than and comparable efficacy to oxybutyrrin in individuals 50 years old or older with overactive bladder:a randomized controlled trial. J Urol,2001,165(5) :1450-1456.

共引文献15

同被引文献52

  • 1张日强,宋希双,吴东军,殷积斌,张仁科,吴洪昌,高春章.自控镇痛泵缓解前列腺切除术后膀胱痉挛的临床应用[J].中国医师杂志,2006,8(6):839-840. 被引量:3
  • 2王文远.平衡针灸学最新理论研究.中国平衡针灸平衡医学杂志,2001,(1):31-31.
  • 3Blaivas JG, Marks BK, Weiss JP, et al. Differential diagnosis of overactive bladder in men. J Urol,2009,182(6) :2814 -2817.
  • 4Cho MC ,Kim HS,Lee CJ,et al. Influence of detrusor overactivity on storage symptoms following potassium -titanyl-phosphate photoseleetive vaporization of the prostate. Urology, 2010,75 ( 6 ) : 1460 - 1466.
  • 5Daniel G, Gunnar T. Muscarinic receptor subtypes in the lower urinary tract, Pharmacology, 2009,83 (5) :259 - 269.
  • 6Homma Y, Yoshida M, Seki N, et al. Symptom assessment tool for overactive bladder syttdrome Overactive bladder symptom score. Urology,2006,68 ( 2 ) : 318 - 323.
  • 7Malaeb BS, Yu X, MeBean AM, et al. National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000 - 2008 ). Urology,2012,79 (5) : 1111 - 1116.
  • 8Pinto F, Racioppi M, Saceo E, et al. Progression, risk factors and sub- sequent medical management of symptomatic benign prostatic hyperplasia. Arch Ital Urol ndrol,2009,81 ( 1 ) : 1 - 8.
  • 9Michel MC. The forefront for novel therapeutic agents based an the pathophysiology of lower urinary tract dysfunction alpha-blockers in the treatment of male voiding dysfunction-how do they work and why they differ in tolerability. J Pharmacol Sci, 2010, 112 ( 1 ) : 151 - 157.
  • 10Andersson KE, Yoshida M. Antimusearinics and the overactive detrusor-which is the main mechanism of action? Eur Urol,2003,43 (1):1 -5.

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部